More articles from Clinical (Oncology: GU)

You have access
Assessing Response to [¹⁷⁷Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria
Kerstin Michalski, Claudius Klein, Tonio Brueggemann, Philipp T Meyer, Cordula Annette Jilg and Juri Ruf

Journal of Nuclear Medicine March 31, 2021, jnumed.120.260836; DOI: https://doi.org/10.2967/jnumed.120.260836
You have access
GRPr antagonist ⁶⁸Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients
Ingrid L Bakker, Alida C Fröberg, Martijn B Busstra, J. Fred Verzijlbergen, Mark Konijnenberg, Geert J. L. H. van Leenders, Ivo G Schoots, Erik de Blois, Wytske M van Weerden, Simone U Dalm, Theodosia Maina-Nock, Berthold Artur Nock and Marion de Jong

Journal of Nuclear Medicine March 31, 2021, jnumed.120.258814; DOI: https://doi.org/10.2967/jnumed.120.258814
You have access
Tumor detection of ¹⁸F-PSMA-1007 in the prostate gland in patients with prostate cancer using prostatectomy specimens as reference method
Elin Tragardh, Athanasios Simoulis, Anders Bjartell and Jonas Jogi

Journal of Nuclear Medicine March 31, 2021, jnumed.121.261993; DOI: https://doi.org/10.2967/jnumed.121.261993
You have access
A Phase II, Open-label study to assess safety and management change using ⁶⁸Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
Asim Afaq, Heather Payne, Reena Davda, John Hines, Gary J.R. Cook, Marie Meagher, Dimitrios Priftakis, Victoria S. Warbey, Anand Kelkar, Clement Orczyk, Anita Mitra, Sarah Needleman, Michael Ferris, Greg Mullen and Jamshed Bomanji

Journal of Nuclear Medicine March 19, 2021, jnumed.120.257527; DOI: https://doi.org/10.2967/jnumed.120.257527
You have access
Current and emerging clinical applications of PSMA-PET diagnostic imaging for prostate cancer
Andrea Farolfi, Letizia Calderoni, Francesco Mattana, Riccardo Mei, Silvi Telo, Stefano Fanti and Paolo Castellucci

Journal of Nuclear Medicine March 12, 2021, jnumed.120.257238; DOI: https://doi.org/10.2967/jnumed.120.257238
You have access
Combination of forced diuresis with additional late imaging in ⁶⁸Ga-PSMA-11 PET/CT – effects on lesion visibility and radiotracer uptake
Ian Alberts, Jan Niklas Huenermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Laeppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh

Journal of Nuclear Medicine March 12, 2021, jnumed.120.257741; DOI: https://doi.org/10.2967/jnumed.120.257741
You have access
Detection efficacy of ¹⁸F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment
Isabel Rauscher, Amir Karimzadeh, Kilian Schiller, Thomas Horn, Calogero D'Alessandria, Charlott Franz, Hannah Wörther, Noemi Nguyen, Stephanie E Combs, Wolfgang Andreas Weber and Matthias Eiber

Journal of Nuclear Medicine March 12, 2021, jnumed.120.260091; DOI: https://doi.org/10.2967/jnumed.120.260091
You have access
PSMA- and GRPR-targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer
Lucia Baratto, Hong Song, Heying Duan, Negin Hatami, Hilary Bagshaw, Mark Buyyounouski, Steven Hancock, Sumit Anil Shah, Sandy Srinivas, Patrick Swift, Farshad Moradi, Guido A Davidzon and Andrei Iagaru

Journal of Nuclear Medicine March 5, 2021, jnumed.120.259630; DOI: https://doi.org/10.2967/jnumed.120.259630
You have access
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted ¹⁸F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, Francois Benard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho and Steven P. Rowe

Journal of Nuclear Medicine February 19, 2021, jnumed.120.259069; DOI: https://doi.org/10.2967/jnumed.120.259069
You have access
Matched-pair comparison of ¹⁸F-DCFPyL PET/CT and ¹⁸F-PSMA-1007 PET/CT in 240 prostate cancer patients; inter-reader agreement and lesion detection rate of suspected lesions
Maurits Wondergem, Friso M van der Zant, Wouter AM Broos and Remco JJ Knol

Journal of Nuclear Medicine February 5, 2021, jnumed.120.258574; DOI: https://doi.org/10.2967/jnumed.120.258574

Main menu

User menu

Search

More articles from Clinical (Oncology: GU)

Pages